{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:40:42Z","timestamp":1790538042219,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,24]],"date-time":"2023-12-24T00:00:00Z","timestamp":1703376000000},"content-version":"am","delay-in-days":357,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100010431","name":"Institut de M\u00e9decine et d'Epid\u00e9miologie Appliqu\u00e9e","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ijantimicag.2022.106702","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T13:17:00Z","timestamp":1670246220000},"page":"106702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Efficacy of ceftazidime-avibactam in various combinations for the treatment of experimental osteomyelitis due to Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2859-8417","authenticated-orcid":false,"given":"Benjamin","family":"Davido","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Claude","family":"Cr\u00e9mieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Vaugier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Gatin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latifa","family":"Noussair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Massias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azzam","family":"Saleh-Mghir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2022.106702_bib0001","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4103\/jms.jms_25_17","article-title":"World Health Organization releases global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics","volume":"32","author":"Shrivastava","year":"2018","journal-title":"J Med Soc"},{"key":"10.1016\/j.ijantimicag.2022.106702_bib0002","first-page":"E149","article-title":"Epidemiology and biomolecular characterization of carbapenem-resistant klebsiella pneumoniae in an Italian hospital","volume":"57","author":"Cristina","year":"2016","journal-title":"J Prev Med Hyg"},{"key":"10.1016\/j.ijantimicag.2022.106702_bib0003","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.3201\/eid2007.121004","article-title":"Deaths attributable to carbapenem-resistant Enterobacteriaceae infections","volume":"20","author":"Falagas","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2022.106702_bib0004","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1086\/657135","article-title":"Bloodstream Infections Caused by Metallo-\u03b2-Lactamase\/Klebsiella pneumoniae Carbapenemase\u2013Producing K. pneumoniae among Intensive Care Unit Patients in Greece: Risk Factors for Infection and Impact of Type of Resistance on Outcomes","volume":"31","author":"Mouloudi","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2022.106702_bib0005","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.otsr.2013.02.011","article-title":"Bacterial epidemiology of osteoarticular infections in a referent center: 10-year study","volume":"99","author":"Tit\u00e9cat","year":"2013","journal-title":"Orthop Traumatol Surg Res"},{"key":"10.1016\/j.ijantimicag.2022.106702_bib0006","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijid.2014.01.028","article-title":"Complex prosthetic joint infections due to carbapenemase-producing Klebsiella pneumoniae: A unique challenge in the era of untreatable infections","volume":"25","author":"de Sanctis","year":"2014","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2022.106702_bib0007","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ijantimicag.2018.10.018","article-title":"Multidrug-resistant and extensively drug-resistant Gram-negative prosthetic joint infections: Role of surgery and impact of colistin administration","volume":"53","author":"Papadopoulos","year":"2019","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.ijantimicag.2022.106702_bib0008","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jgar.2020.08.007","article-title":"Case series of carbapenemase-producing Enterobacteriaceae osteomyelitis: Feel it in your bones","volume":"23","author":"Davido","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ijantimicag.2022.106702_bib0009","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1086\/516135","article-title":"Experimental models of bone and prosthetic joint infections","volume":"25","author":"Cr\u00e9mieux","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2022.106702_bib0010","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1093\/cid\/civ482","article-title":"2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults","volume":"61","author":"Berbari","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2022.106702_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2017.03.030","article-title":"Reinforcement of an antimicrobial stewardship task force aims at a better use of antibiotics of last resort: the COLITIFOS study","volume":"50","author":"Davido","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2022.106702_bib0012","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1473-3099(16)30257-2","article-title":"Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study","volume":"17","author":"Grundmann","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2022.106702_bib0013","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1093\/jac\/dkz257","article-title":"Efficacy of colistin alone and in various combinations for the treatment of experimental osteomyelitis due to carbapenemase-producing Klebsiella pneumoniae","volume":"74","author":"Cr\u00e9mieux","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2022.106702_bib0014","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.clinthera.2016.01.018","article-title":"Ceftazidime-Avibactam: A Novel Cephalosporin\/\u03b2-Lactamase Inhibitor Combination for the Treatment of Resistant Gram-negative Organisms","volume":"38","author":"Sharma","year":"2016","journal-title":"Clin Ther"},{"key":"10.1016\/j.ijantimicag.2022.106702_bib0015","first-page":"61","article-title":"Ceftazidime-avibactam as salvage therapy for infections caused by carbapenem-resistant organisms. Antimicrob","author":"Temkin","year":"2017","journal-title":"Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2022.106702_bib0016","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1128\/AAC.17.4.591","article-title":"Treatment of experimental staphylococcal osteomyelitis with rifampin and trimethoprim, alone and in combination","volume":"17","author":"Norden","year":"1980","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2022.106702_bib0017","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s40261-015-0283-9","article-title":"Safety and pharmacokinetics of single and multiple ascending doses of avibactam alone and in combination with ceftazidime in healthy male volunteers: results of two randomized, placebo-controlled studies","volume":"35","author":"Merdjan","year":"2015","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.ijantimicag.2022.106702_bib0018","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/infdis\/155.1.93","article-title":"Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration","volume":"155","author":"Moore","year":"1987","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2022.106702_bib0019","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s15010-021-01577-x","article-title":"Mono vs. combo regimens with novel beta-lactam\/beta-lactamase inhibitor combinations for the treatment of infections due to carbapenemase-producing Enterobacterales: insights from the literature","volume":"49","author":"Meini","year":"2021","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2022.106702_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.00314","article-title":"Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) Among Carbapenem-Resistant Enterobacteriaceae Isolated From Adult and Children Patients in China","volume":"10","author":"Han","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ijantimicag.2022.106702_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106246","article-title":"In vitro pharmacokinetics\/pharmacodynamics of continuous ceftazidime infusion alone and in combination with colistin against Pseudomonas aeruginosa biofilm","volume":"57","author":"G\u00f3mez-Junyent","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2022.106702_bib0022","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s40121-021-00479-7","article-title":"Ceftazidime-Avibactam in Combination with In Vitro Non-susceptible Antimicrobials Versus Ceftazidime-Avibactam in Monotherapy in Critically Ill Patients with Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective Cohort Study","volume":"10","author":"Zheng","year":"2021","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.ijantimicag.2022.106702_bib0023","first-page":"128","article-title":"Ceftazidime\/Avibactam for Refractory Bacteremia, Vertebral Diskitis\/Osteomyelitis with Pre-Vertebral Abscess and Bilateral Psoas Pyomyositis Secondary to Klebsiella Pneumoniae Carbapenemase-Producing Bacteria (KPC)","volume":"37","author":"De Le\u00f3n-Borr\u00e1s","year":"2018","journal-title":"P R Health Sci J"},{"key":"10.1016\/j.ijantimicag.2022.106702_bib0024","first-page":"e12837","article-title":"Carbapenem-resistant Klebsiella pneumoniae vertebral osteomyelitis in a renal transplant recipient treated with ceftazidime-avibactam. Transpl","volume":"20","author":"Cani","year":"2018","journal-title":"Infect Dis"},{"key":"10.1016\/j.ijantimicag.2022.106702_bib0025","first-page":"1","article-title":"Prosthetic Joint Infection from Carbapenemase-Resistant Klebsiella pneumoniae Successfully Treated with Ceftazidime-Avibactam","author":"Schimmenti","year":"2018","journal-title":"Case Rep Infect Dis"},{"key":"10.1016\/j.ijantimicag.2022.106702_bib0026","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/jac\/dkab069","article-title":"Effectiveness of vancomycin plus cloxacillin compared with vancomycin, cloxacillin and daptomycin single therapies in the treatment of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in a rabbit model of experimental endocarditis","volume":"76","author":"Casta\u00f1eda","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2022.106702_bib0027","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciab176","article-title":"Ceftazidime-avibactam use for KPC-Kp infections: a retrospective observational multicenter study","author":"Tumbarello","year":"2021","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857922002278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857922002278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:43:57Z","timestamp":1760377437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857922002278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0924857922002278"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2022.106702","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of ceftazidime-avibactam in various combinations for the treatment of experimental osteomyelitis due to Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2022.106702","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106702"}}